Literature DB >> 15504816

Obliterative bronchiolitis after lung transplantation: a repetitive multiple injury airway disease.

Jim J Egan.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15504816     DOI: 10.1164/rccm.2408010

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  7 in total

Review 1.  Gastroesophageal reflux and altered motility in lung transplant rejection.

Authors:  J M Castor; R K Wood; A J Muir; S M Palmer; R A Shimpi
Journal:  Neurogastroenterol Motil       Date:  2010-05-26       Impact factor: 3.598

2.  Loss of basal cells precedes bronchiolitis obliterans-like pathological changes in a murine model of chlorine gas inhalation.

Authors:  Emily G O'Koren; Brigid L M Hogan; Michael Dee Gunn
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

Review 3.  Foregut Dysmotility in the Lung Transplant Patient.

Authors:  Danny Wong; Walter W Chan
Journal:  Curr Gastroenterol Rep       Date:  2021-10-15

Review 4.  Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.

Authors:  Jean-François Cordier
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

5.  Chronic rejection pathology after orthotopic lung transplantation in mice: the development of a murine BOS model and its drawbacks.

Authors:  Stéphanie De Vleeschauwer; Wolfgang Jungraithmayr; Shana Wauters; Stijn Willems; Manuela Rinaldi; Annemie Vaneylen; Stijn Verleden; Anna Willems-Widyastuti; Ken Bracke; Guy Brusselle; Erik Verbeken; Dirk Van Raemdonck; Geert Verleden; Bart Vanaudenaerde
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

Review 6.  Role of gastroesophageal reflux disease in lung transplantation.

Authors:  Kelly E Hathorn; Walter W Chan; Wai-Kit Lo
Journal:  World J Transplant       Date:  2017-04-24

Review 7.  Chronic allograft dysfunction.

Authors:  Christiane Knoop; Marc Estenne
Journal:  Clin Chest Med       Date:  2011-06       Impact factor: 2.878

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.